纤维化解的化学调整
Alexey M Shibeko1,2, Ivan S Ilin3,4, Nadezhda A Podoplelova1,2
1Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, 109029 Moscow, Russia.
Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
概括
纤维解析,即血液凝块的分解,对于血液静止至关重要. 功能失调的纤维素分解可能导致出血或血栓形成,需要新的治疗策略,超出目前的抗凝块药物.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 药理学 药理学 是一个学科.
背景情况:
- 纤维素分解是纤维素凝块的酶溶解,对于维持血液静止至关重要.
- 纤维解质失衡会导致病态出血或增加血栓形成的风险.
- 目前的治疗方法,如复合组织等质激素激活剂,向急性血栓溶解.
研究的目的:
- 对调节纤维解质的低分子量化合物进行审查.
- 讨论它们的作用机制和潜在的治疗应用.
- 探索未来的药物开发,包括计算建模.
主要方法:
- 关于纤维解析调节和治疗剂的文献综述.
- 对低分子量化合物的作用机制的分析.
- 在纤维素分解药物发现中的计算建模的讨论.
主要成果:
- 低分子量化合物提供纤维素分解的向调节.
- 这些化合物可以治疗除了血液学之外的纤维解质功能障碍,例如纤维化.
- 它们通过影响纤维素分解而不会显著改变其他静血元件而提供优势.
结论:
- 使用低分子量化合物向调节纤维素分解,是一个有前途的治疗途径.
- 需要在计算模型的帮助下进行进一步的研究,以开发用于各种疾病的新药.
- 这些药物可以改善纤维素分解功能障碍的长期纠正.
相关概念视频
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K


